Cytokinetics, Incorporated announced the granting of stock options and restricted stock units (RSUs) to nine new employees on December 31, 2024, as part of their employment inducement. The company ...

The fair value estimate for Cytokinetics has shifted from US$79.56 to US$92.94, signaling a fresh look at what the shares might be worth in updated models. That change lines up with recent analyst ...

That morning, Cytokinetics announced that Sanofi has acquired the Greater China development and commercialization rights to aficamten from Chinese healthcare company Corxel. This is a drug targeting ...

(RTTNews) - Stock of Cytokinetics, Incorporated (CYTK) tumbled 14 percent on Thursday after rumoured deal fail to reach a conclusion. Currently, Cytokinetics stock is dropping 14.44 percent, to $86.96 ...

SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced its intention to offer, subject to market conditions and other factors, $550.0 million ...

It has a new partner in a crucial market across the Pacific ocean. This occurred after a transfer of development and commercialization rights to one of the company's drugs. That morning, Cytokinetics ...